HIGHLIGHTS
Economic burden of atopic dermatitis in adults
Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller
Costs of productivity loss had larger impact on total costs. Patients with atopic dermatitis using systemic immunosuppressive treatment incur considerable direct costs and cots of productivity loss.
Efficacy of secukinumab-to-ixekizumab switch
Shany Sherman, Efrat Solomon Cohen, Iris Amitay-Laish, Emmilia Hodak, Lev Pavlovsky
Patients with moderate-to-severe psoriasis seem to be amenable to treatment with izekizumab following secukinumab failure.
Etretinate for cutaneous-type adult T-cell leukemia-lymphoma
Kentaro Yonekura, Koichiro Takeda, Nobuyo Kawakami, Tamotsu Kanzaki, Takuro Kanekura, Atae Utsunomiya
The results given in this report suggest that etretinate is a promising treatment option for cutaneous-type adult T-cell leukemia-lymphoma.
Wound care in a child with epidermolysis bullosa
Petra Mauritz, Marcel F. Jonkman, Sanne S. Visser, Catrin Finkenauer, José C. Duipmans, Mariët Hagedoorn
Parents and children should learn which coping strategies are helpful for themselves and for each other in the context of wound care.
Interest in skin cancer: a Google search term analysis
Linda Tizek, Maximilian C. Schielein, Melvin Rüth, Rolf-Markus Szeimies, Wolfgang G. Philipp-Dormston, Stephan A. Braun, Christine Hecker, Bernadette Eberlein, Tilo Biedermann, Alexander G.S. Zink
Analysis of the differences in search bevaviour between cities could help to identify areas with a high need for targeted prevention campaigns.
Diagnosis of mycosis fungoides after dupilumab for misdiagnosed atopic dermatitis
Takahito Chiba, Takuya Nagai, Shin-ichi Osada, Motomu Manabe
This is the first report to describe a case of mucosis fungoides diagnosed after administration of dupilumab for atopic dermatitis.
Granuloma faciale treated successfully with colchicine
Chika Ohata, Takekuni Nakama
.
